Ainos, Inc.: Ainos Provides Insights Into Its Ai Nose Technology

Ainos Inc. is a diversified medtech company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine. Their AI Nose technology is an array of digital nose sensors used to detect volatile organic compounds (VOCs) and leverage deep neural networks, clinical trial data labeling, and supervised machine learning to accurately identify VOC samples. AI Nose has the potential to revolutionize telehealth and point-of-care testing, and position Ainos to capitalize on the US$256 billion STI testing market.